1. Ruchlin HS, Elkin EB, Paget SA. Assessing cost-effectiveness studies in rheumatoid arthritis and osteoarthritis. Arthritis Care Res 1997;10:413-421. [PubMed Abstract]
2. Ruchlin HS, Elkin EB, MacKenzie CR, Williams-Russo P, Allegrante JP. Determining the cost of a clinical intervention through the use of shadow pricing. Arthritis Care Res 1997;10:343-351. [PubMed Abstract]
3. Ruchlin HS, Elkin EB, Allegrante JP. The economic impact of a multifactorial intervention to improve postoperative rehabilitation of hip fracture patients. Arthritis Care Res 2001;45:446-52. [PubMed Abstract]
4. Finkel ML and Elkin E. Trends in birth rates: New York City 1970-1995. J Community Health 2001;26:407-421. [PubMed Abstract]
5. Heffner LJ, Elkin E, Fretts RC. Impact of labor induction, gestational age, and maternal age on cesarean delivery rates. Obstet Gynecol 2003;102:287-293. [PubMed Abstract]
6. Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC. HER-2 testing and trastuzumab therapy for metastatic breast cancer: A cost-effectiveness analysis. J Clin Oncol 2004; 22:854-63. [PubMed Abstract]
7. Fretts RC, Elkin EB, Myers ER, Heffner LJ. Should older women have antepartum testing to prevent unexplained stillbirth? Obstet Gynecol 2004;104:56-64. [PubMed Abstract]
8. Elkin EB, Cowen ME, Cahill D, Steffel M, Kattan MW. Preference assessment method affects decision-analytic recommendations: A prostate cancer treatment example. Med Decis Making, 2004;24:504-510. [PubMed Abstract]
9. Bach PB, Elkin EB, Pastorino U, Kattan MW, Mushlin AI, Begg CB, Parkin DM. Benchmarking lung cancer mortality rates in current and former smokers. Chest, 2004;126:1742-1749. href="javascript:openPMID(15596668)">[PubMed Abstract]
10. Saranchuk JW, Kattan MW, Elkin E, Touijer AK, Scardino PT, Eastham JA. Achieving optimal outcomes after radical prostatectomy. J Clin Oncol 2005;23:4146-4151. [PubMed Abstract]
11. Panageas KS, Elkin EB, DeAngelis LM, Ben Porat L, Abrey LE. Trends in survival from primary central nervous system lymphoma 1975-1999: a population-based analysis. Cancer, 2005; 104:2466-2472. [PubMed Abstract]
12. Elkin EB, Weinstein MC, Kuntz KM, Bunnell CA, Weeks JC. Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs. Breast Cancer Res Treat, 2005; 93:25-34. [PubMed Abstract]
13. Elkin EB, Hudis C, Begg CB, Schrag DS, The effect of changes in tumor size on breast cancer survival in the U.S., 1975-1999. Cancer, 2005; 104:1149-57. [PubMed Abstract]
14. Schrag D, Xu F, Hanger M, Elkin E, Bickell NA, Bach PB. Fragmentation of care for frequently hospitalized urban residents. Med Care, 2006; 44:560-567. [PubMed Abstract]
15. Elkin EB, Hurria A, Mitra N, Schrag D, Panageas KS. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol, 2006; 24:2757-2764. [PubMed Abstract]
16. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making, 2006; 26:565-574. [PubMed Abstract]
17. Ballas LK, Elkin EB, Schrag D, Minsky BD, Bach PB.. Radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys, 2006; 66:1204-1211. [PubMed Abstract]
18. Elkin EB, Vickers AJ, Kattan MW. Primer: using decision analysis to improve clinical decision making in urology. Nat Clin Pract Urol. 2006; 3:439-448. [PubMed Abstract]
